Mahamaya Lifesciences Ltd Market Cap

Market Capitalization of Mahamaya Lifesciences Ltd

Image

Mahamaya Lifesciences Ltd

NSE: MAHALIFE

Market Cap

₹ 363.71 crore

Last updated on: Mar 27, 2026

Key Highlights

  • The Market Cap of Mahamaya Lifesciences Ltd is ₹ 363.71 crore as of 27 Mar 26 The Latest Trading Price of Mahamaya Lifesciences Ltd is ₹ 155.4 as of 27 Mar 15:30 .
Image

Mahamaya Lifesciences Ltd

NSE: MAHALIFE

Share Price

₹ 155.4

7.40 (5.00%)

stock direction

Last updated on: Mar 27, 2026

Market Price of Mahamaya Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Mahamaya Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
27 Mar 2026155.4
25 Mar 2026148
24 Mar 2026143.95
23 Mar 2026137.15
20 Mar 2026139.25
19 Mar 2026143
18 Mar 2026141.65
17 Mar 2026144
16 Mar 2026148.5
13 Mar 2026152.1

BlinkX Score for Mahamaya Lifesciences Ltd

Asset Value vs Market Value of Mahamaya Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Mahamaya Lifesciences Ltd

No data available

Historical P/E Ratio of Mahamaya Lifesciences Ltd

No data available

* All values are in %

Historical Revenue of Mahamaya Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Mahamaya Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Mahamaya Lifesciences Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Mahamaya Lifesciences Ltd

  • Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as 'Mahamaya Life Sciences Private Limited' by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002.
  • Further, Company's name was changed from 'Mahamaya Life Sciences Private Limited' to 'Mahamaya Lifesciences Private Limited' dated February 15, 2016.
  • The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre. The Company specializes in manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs).
  • The Company began the journey by focusing on import and registration of vital pesticide molecules.
  • It imported these molecules and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India.

Mahamaya Lifesciences Ltd News Hub

Shares of Mahamaya Lifesciences list in MT Group

The equity shares of Mahamaya Lifesciences (Scrip Code: 544611) are listed effective 18 November 202

Read more

18 Nov 25

BSE SME Mahamaya Lifesciences debuts with a modest pulse

The scrip was listed at Rs 116, a premium of 1.75% over the initial public offer (IPO) price. The st

Read more

18 Nov 25

Mahamaya Lifesciences to announce Quarterly Result

Mahamaya Lifesciences will hold a meeting of the Board of Directors of the Company on 2 December 202

Read more

27 Nov 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Mahamaya Lifesciences Ltd Market Cap

What is the market cap of Mahamaya Lifesciences Ltd?

As of March 30, 2026, Mahamaya Lifesciences Ltd has a market capitalization of ₹363.71, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Mahamaya Lifesciences Ltd's market capitalization?

Mahamaya Lifesciences Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Mahamaya Lifesciences Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Mahamaya Lifesciences Ltd's market capitalization change?

Mahamaya Lifesciences Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions